
Chapter 118
ALZHEIMER’S DISEASE AND RELATED DEMENTIAS RESEARCH
 Findings
 Repealed. 
 Omitted
 The National Alzheimer’s Project
(a)
 Definition of Alzheimer’s
In this Act, the term “Alzheimer’s” means Alzheimer’s disease and related dementias.




(b)
 Establishment
There is established in the Office of the Secretary of Health and Human Services the National Alzheimer’s Project (referred to in this Act as the “Project”).




(c)
 Purpose of the Project
The Secretary of Health and Human Services, or the Secretary’s designee, shall—
(1)
 be responsible for the creation and maintenance of an integrated national plan to overcome Alzheimer’s;




(2)
 provide information and coordination of Alzheimer’s research and services across all Federal agencies;




(3)
 accelerate the development of treatments that would prevent, halt, or reverse the course of Alzheimer’s;




(4)
 improve the—
(A)
 early diagnosis of Alzheimer’s disease; and




(B)
 coordination of the care and treatment of citizens with Alzheimer’s;






(5)
 ensure the inclusion of ethnic and racial populations at higher risk for Alzheimer’s or least likely to receive care, in clinical, research, and service efforts with the purpose of decreasing health disparities in Alzheimer’s; and




(6)
 coordinate with international bodies to integrate and inform the fight against Alzheimer’s globally.




(d)
 Duties of the Secretary
(1)
 In general
The Secretary of Health and Human Services, or the Secretary’s designee, shall—
(A)
 oversee the creation and updating of the national plan described in paragraph (2); and




(B)
 use discretionary authority to evaluate all Federal programs around Alzheimer’s, including budget requests and approvals.






(2)
 National plan
The Secretary of Health and Human Services, or the Secretary’s designee, shall carry out an annual assessment of the Nation’s progress in preparing for the escalating burden of Alzheimer’s, including both implementation steps and recommendations for priority actions based on the assessment.






(e)
 Advisory Council
(1)
 In general
There is established an Advisory Council on Alzheimer’s Research, Care, and Services (referred to in this Act as the “Advisory Council”).






(2)
 Membership
(A)
 Federal members
The Advisory Council shall be comprised of the following experts:
(i)
 A designee of the Centers for Disease Control and Prevention.




(ii)
 A designee of the Administration on Aging.




(iii)
 A designee of the Centers for Medicare & Medicaid Services.




(iv)
 A designee of the Indian Health Service.




(v)
 A designee of the Office of the Director of the National Institutes of Health.




(vi)
 The Surgeon General.




(vii)
 A designee of the National Science Foundation.




(viii)
 A designee of the Department of Veterans Affairs.




(ix)
 A designee of the Food and Drug Administration.




(x)
 A designee of the Agency for Healthcare Research and Quality.






(B)
 Non-Federal members
In addition to the members outlined in subparagraph (A), the Advisory Council shall include 12 expert members from outside the Federal Government, which shall include—
(i)
 2 Alzheimer’s patient advocates;




(ii)
 2 Alzheimer’s caregivers;




(iii)
 2 health care providers;




(iv)
 2 representatives of State health departments;




(v)
 2 researchers with Alzheimer’s-related expertise in basic, translational, clinical, or drug development science; and




(vi)
 2 voluntary health association representatives, including a national Alzheimer’s disease organization that has demonstrated experience in research, care, and patient services, and a State-based advocacy organization that provides services to families and professionals, including information and referral, support groups, care consultation, education, and safety services.








(3)
 Meetings
The Advisory Council shall meet quarterly and such meetings shall be open to the public.






(4)
 Advice
The Advisory Council shall advise the Secretary of Health and Human Services, or the Secretary’s designee.






(5)
 Annual report
The Advisory Council shall provide to the Secretary of Health and Human Services, or the Secretary’s designee and Congress—
(A)
 an initial evaluation of all federally funded efforts in Alzheimer’s research, clinical care, and institutional-, home-, and community-based programs and their outcomes;




(B)
 initial recommendations for priority actions to expand, eliminate, coordinate, or condense programs based on the program’s performance, mission, and purpose;




(C)
 initial recommendations to—
(i)
 reduce the financial impact of Alzheimer’s on—
(I)
 Medicare and other federally funded programs; and




(II)
 families living with Alzheimer’s disease; and






(ii)
 improve health outcomes; and






(D)
 annually thereafter, an evaluation of the implementation, including outcomes, of the recommendations, including priorities if necessary, through an updated national plan under subsection (d)(2).






(6)
 Termination
The Advisory Council shall terminate on 
December 31, 2025
.






(f)
 Data sharing
Agencies both within the Department of Health and Human Services and outside of the Department that have data relating to Alzheimer’s shall share such data with the Secretary of Health and Human Services, or the Secretary’s designee, to enable the Secretary, or the Secretary’s designee, to complete the report described in subsection (g).




(g)
 Annual report
The Secretary of Health and Human Services, or the Secretary’s designee, shall submit to Congress—
(1)
 an annual report that includes an evaluation of all federally funded efforts in Alzheimer’s research, clinical care, and institutional-, home-, and community-based programs and their outcomes;




(2)
 an evaluation of all federally funded programs based on program performance, mission, and purpose related to Alzheimer’s disease;




(3)
 recommendations for—
(A)
 priority actions based on the evaluation conducted by the Secretary and the Advisory Council to—
(i)
 reduce the financial impact of Alzheimer’s on—
(I)
 Medicare and other federally funded programs; and




(II)
 families living with Alzheimer’s disease; and






(ii)
 improve health outcomes;






(B)
 implementation steps; and




(C)
 priority actions to improve the prevention, diagnosis, treatment, care, institutional-, home-, and community-based programs of Alzheimer’s disease for individuals with Alzheimer’s disease and their caregivers; and






(4)
 an annually updated national plan.




(h)
 Sunset
The Project shall expire on 
December 31, 2025
.




 Transferred
 Repealed. 
 Transferred
 Repealed. 
 Providing information for personnel of Social Security Administration
(a)
 The Secretary shall develop a mechanism to ensure the prompt provision of the most current information concerning Alzheimer’s disease and related dementias to the Commissioner of Social Security, particularly information which will increase the understanding of personnel of the Social Security Administration concerning such disease and dementias.


(b)
 The Commissioner of Social Security shall ensure that information received under subsection (a) of this section is provided to personnel of the Social Security Administration, particularly personnel involved in the process of determining, for purposes of titles II and XVI of the Social Security Act [
42 U.S.C. 401
 et seq., 1381 et seq.], whether an individual is under a disability.


 Education of public, individuals with Alzheimer’s disease and their families, and health and long-term care providers
(a)
 Training models grants
(1)
 Grants
The Director of the National Institute on Aging may award grants to eligible entities to assist the entities in developing and evaluating model training programs—
(A)
 for—
(i)
 health care professionals, including mental health professionals;




(ii)
 health care paraprofessionals;




(iii)
 personnel, including information and referral, case management, and in-home services personnel (including personnel receiving support under the Older Americans Act of 1965 (
42 U.S.C. 3001
 et seq.)), providing supportive services to the elderly and the families of the elderly;




(iv)
 family caregivers providing care and treatment for individuals with Alzheimer’s disease and related disorders; and




(v)
 personnel of local organizations (including community groups, business and labor groups, and religious, educational, and charitable organizations) that have traditionally not been involved in planning and developing long-term care services; and






(B)
 with attention to such variables as—
(i)
 curricula development for training and continuing education programs;




(ii)
 care setting; and




(iii)
 intervention technique.








(2)
 Eligible entity
To be eligible to receive grants under this subsection, an entity shall be—
(A)
 an educational institution providing training and education in medicine, psychology, nursing, social work, gerontology, or health care administration;




(B)
 an educational institution providing preparatory training and education of personnel for nursing homes, hospitals, and home or community settings; or




(C)
 an Alzheimer’s Disease Research Center described in 
section 285e–2(a) of this title
.






(b)
 Educational grants
The Director of the National Institute on Aging is authorized to make grants to public and nonprofit private entities to assist such entities in establishing programs, for educating health care providers and the families of individuals with Alzheimer’s disease or related disorders, regarding—
(1)
 caring for individuals with such diseases or disorders; and




(2)
 the availability in the community of public and private sources of assistance, including financial assistance, for caring for such individuals.




(c)
 Award of grants
In awarding grants under this section, the Director of the National Institute on Aging shall—
(1)
 award the grants on the basis of merit;




(2)
 award the grants in a manner that will ensure access to the programs described in subsections (a) and (b) of this section by rural, minority, and underserved populations throughout the country; and




(3)
 ensure that the grants are distributed among the principal geographic regions of the United States.




(d)
 Application
To be eligible to receive a grant under this section, an entity shall submit an application to the Director of the National Institute on Aging at such time, in such manner, and containing or accompanied by such information, as the Director may reasonably require, including, at a minimum, an assurance that the entity will coordinate programs provided under this section with the State agency designated under section 305(a)(1) of the Older Americans Act of 1965 [
42 U.S.C. 3025(a)(1)
], in the State in which the entity will provide such programs.




(e)
 Coordination
The Director of the National Institute on Aging shall coordinate the award of grants under this section with the heads of other appropriate agencies, including the Commissioner of the Administration on Aging.




 Education programs for safety and transportation personnel
The Director of the National Institute on Aging, through centers supported under 
 Authorization of appropriations
(a)
 To carry out sections 11291 and 11293 of this title, there are authorized to be appropriated $1,000,000 for each of the fiscal years 1988 through 1991.


(b)
 There are authorized to be appropriated such sums as may be necessary for each of the fiscal years 1992 through 1996, to carry out 
section 11292 of this title
.


